IL6 and neoplasm: Studies proved that IL-6, a cytokine with various roles in inflammatory condition, can initiate epithelial–mesenchymal transition (EMT) in tumour cells, and this is evidenced by the decrease of E-cadherin and increase of N-cadherin and vimentin expression which boosting the movement and infiltration of tumour cells [29].